MicroRNAs in endothelial senescence and atherosclerosis

Journal of Cardiovascular Translational Research

Volumn 6, Issue 6, 2013, Pages 924-930

  Menghini, Rossella ^a   Casagrande, Viviana ^a   Federici, Massimo ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Atherosclerosis; Cellular senescence; Endothelial dysfunction; MicroRNA

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 126; MICRORNA 146; MICRORNA 146A; MICRORNA 21; MICRORNA 217; MICRORNA 34; MICRORNA 34A; MICRORNA 92A; SIRTUIN 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOPHAGY; CARDIOVASCULAR DISEASE; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; DISEASE COURSE; DOWN REGULATION; ENDOTHELIAL SENESCENCE; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROCESSING; SENESCENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; ATHEROSCLEROSIS; AUTOPHAGY; CELL AGING; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; INFLAMMATION; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84890556265     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-013-9487-7     Document Type: Article

References (53)

1. Davignon, J.; Ganz, P. (2004). Role of endothelial dysfunction in atherosclerosis. Circulation, 109, III27-III32.
2. Kim, V. N. (2005). MicroRNA biogenesis: coordinated cropping and dicing. Nature Reviews Molecular Cell Biology, 6, 376-385.
3. Krützfeldt, J.; Stoffel, M. (2006). MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metabolism, 4, 9-12.
4. Krützfeldt, J.; Poy, M. N.; Stoffel, M. (2006). Strategies to determine the biological function of microRNAs. Nature Genetics, 38, S14-S19.
5. Vasudevan, S.; Tong, Y.; Steitz, J. A. (2007). Switching from repression to activation: microRNAs can up-regulate translation. Science, 318, 1931-1934.
6. Minamino, T.; Komuro, I. (2007). Vascular cell senescence: contribution to atherosclerosis. Circulation Research, 100, 15-26.
7. Minamino, T.; Miyauchi, H.; Yoshida, T.; Ishida, Y.; Yoshida, H.; Komuro, I. (2002). Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation, 105, 1541-1544.
8. Fridman, A. L.; Tainsky, M. A. (2008). Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene, 27, 5975-5987.
9. Gorospe, M.; Abdelmohsen, K. (2011). Microregulators come of age in senescence. Trends in Genetics, 27, 233-241.
10. Kuehbacher, A.; Urbich, C.; Zeiher, A. M.; Dimmeler, S. (2007). Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circulation Research, 101, 59-68.
11. Suárez, Y.; Fernández-Hernando, C.; Pober, J. S.; Sessa, W. C. (2007). Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circulation Research, 100, 1164-1173.
12. Ji, R.; Cheng, Y.; Yue, J.; Yang, J.; Liu, X.; Chen, H.; et al. (2007). MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circulation Research, 100, 1579-1588.
13. Weber, C.; Noels, H. (2011). Atherosclerosis: current pathogenesis and therapeutic options. Nature Medicine, 17, 1410-1422.
14. Kong, W.; Zhao, J. J.; He, L.; Cheng, J. Q. (2009). Strategies for profiling microRNA expression. Journal of Cellular Physiology, 218, 22-25.
15. Menghini, R.; Casagrande, V.; Cardellini, M.; Martelli, E.; Terrinoni, A.; Amati, F.; et al. (2009). MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation, 120, 1524-1532.
16. Ito, T.; Yagi, S.; Yamakuchi, M. (2010). MicroRNA-34a regulation of endothelial senescence. Biochemical and Biophysical Research Communications, 398, 735-740.
17. Haigis, M. C.; Guarente, L. P. (2006). Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes & Development, 20, 2913-2921.
18. Mattagajasingh, I.; Kim, C. S.; Naqvi, A.; Yamamori, T.; Hoffman, T. A.; Jung, S. B.; et al. (2007). SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proceedings of the National Academy of Sciences of the United States of America, 104, 14855-14860.
19. Langley, E.; Pearson, M.; Faretta, M.; Bauer, U. M.; Frye, R. A.; Minucci, S.; et al. (2002). Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO Journal, 21, 2383-2396.
20. Alcendor, R. R.; Gao, S.; Zhai, P.; Zablocki, D.; Holle, E.; Yu, X.; et al. (2007). Sirt1 regulates aging and resistance to oxidative stress in the heart. Circulation Research, 100, 1512-1521.
21. Vasa-Nicotera, M.; Chen, H.; Tucci, P.; Yang, A. L.; Saintigny, G.; Menghini, R.; et al. (2011). MiR-146a is modulated in human endothelial cell with aging. Atherosclerosis, 217, 326-330.
22. LaRocca, T. J.; Henson, G. D.; Thorburn, A.; Sindler, A. L.; Pierce, G. L.; Seals, D. R. (2012). Translational evidence that impaired autophagy contributes to arterial ageing. Journal de Physiologie, 590, 3305-3316.
23. Gibbings, D.; Mostowy, S.; Jay, F.; Schwab, Y.; Cossart, P.; Voinnet, O. (2012). Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nature Cell Biology, 14, 1314-1321.
24. Lee, I. H.; Cao, L.; Mostoslavsky, R.; Lombard, D. B.; Liu, J.; Bruns, N. E.; et al. (2008). A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proceedings of the National Academy of Sciences of the United States of America, 105, 3374-3379.
25. Federici, M.; Hribal, M. L.; Menghini, R.; Kanno, H.; Marchetti, V.; Porzio, O.; et al. (2005). Timp3 deficiency in insulin receptor- haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. The Journal of Clinical Investigation, 115, 3494-3505.
26. Menghini, R.; Menini, S.; Amoruso, R.; Fiorentino, L.; Casagrande, V.; Marzano, V.; et al. (2009). Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology, 136, 663-672.
27. Cardellini, M.; Menghini, R.; Luzi, A.; Davato, F.; Cardolini, I.; D'Alfonso, R.; et al. (2011). Decreased IRS2 and TIMP3 expression in monocytes from offspring of type 2 diabetic patients is correlated with insulin resistance and increased intima-media thickness. Diabetes, 60, 3265-3270.
28. Casagrande, V.; Menghini, R.; Menini, S.; Marino, A.; Marchetti, V.; Cavalera, M.; et al. (2012). Overexpression of tissue inhibitor of metalloproteinase 3 in macrophages reduces atherosclerosis in low-density lipoprotein receptor knockout mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 32, 74-81.
29. Menghini, R.; Casagrande, V.; Menini, S.; Marino, A.; Marzano, V.; Hribal, M. L.; et al. (2012). TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice. Diabetes, 61, 454-462.
30. Fiorentino, L.; Cavalera, M.; Menini, S.; Marchetti, V.; Mavilio, M.; Fabrizi, M.; et al. (2013). Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay. EMBO Molecular Medicine, 5, 441-455.
31. Cardellini, M.; Menghini, R.; Martelli, E.; Casagrande, V.; Marino, A.; Rizza, S.; et al. (2009). TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes, 58, 2396-2401.
32. Greco, S.; Fasanaro, P.; Castelvecchio, S.; D'Alessandra, Y.; Arcelli, D.; Di Donato, M.; et al. (2012). MicroRNA dysregulation in diabetic ischemic heart failure patients. Diabetes, 61, 1633-1641.
33. Wang, S.; Aurora, A. B.; Johnson, B. A.; Qi, X.; McAnally, J.; Hill, J. A.; et al. (2008). The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Developmental Cell, 15, 261-271.
34. Harris, T. A.; Yamakuchi, M.; Ferlito, M.; Mendell, J. T.; Lowenstein, C. J. (2008). MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proceedings of the National Academy of Sciences of the United States of America, 105, 1516-1521.
35. Bonauer, A.; Carmona, G.; Iwasaki, M.; Mione, M.; Koyanagi, M.; Fischer, A.; et al. (2009). MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science, 324, 1710-1713.
36. Fang, Y.; Davies, P. F. (2012). Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium. Arteriosclerosis, Thrombosis, and Vascular Biology, 32, 979-987.
37. Sabatel, C.; Malvaux, L.; Bovy, N.; Deroanne, C.; Lambert, V.; Gonzalez, M. L.; et al. (2011). MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells. PLoS One, 6, e16979.
38. Zhou, J.; Wang, W. W.; Subramaniam, S.; Shyy, J. Y.; Chiu, J. J.; Li, J. Y.; et al. (2011). MicroRNA-21 targets peroxisome proliferators-activated receptor-α in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proceedings of the National Academy of Sciences of the United States of America, 108, 10355-10360.
39. Chen, L. J.; Lim, S. H.; Yeh, Y. T.; Lien, S. C.; Chiu, J. J. (2012). Roles of microRNAs in atherosclerosis and restenosis. Journal of Biomedical Science, 19, 79.
40. Raitoharju, E.; Lyytikäinen, L. P.; Levula, M.; Oksala, N.; Mennander, A.; Tarkka, M.; et al. (2011). MiR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis, 219, 211-217.
41. Li, T.; Cao, H.; Zhuang, J.; Wan, J.; Guan, M.; Yu, B.; et al. (2011). Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clinica Chimica Acta, 412, 66-70.
42. Takahashi, Y.; Satoh, M.; Minami, Y.; Tabuchi, T.; Itoh, T.; Nakamura, M. (2010). Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels. Clinical Science (London, England), 119, 395-405.
43. Guo, M.; Mao, X.; Ji, Q.; Lang, M.; Li, S.; Peng, Y.; et al. (2010). MiR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome. Immunology and Cell Biology, 88, 555-564.
44. Du, F.; Zhou, J.; Gong, R.; Huang, X.; Pansuria, M.; Virtue, A.; et al. (2012). Endothelial progenitor cells in atherosclerosis. Frontiers in Bioscience, 17, 2327-2349.
45. Zhang, Q.; Kandic, I.; Kutryk, M. J. (2011). Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease. Biochemical and Biophysical Research Communications, 405, 42-46.
46. Zhao, T.; Li, J.; Chen, A. F. (2010). MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. American Journal of Physiology, Endocrinology and Metabolism, 299, E110-E116.
47. Zernecke, A.; Bidzhekov, K.; Noels, H.; Shagdarsuren, E.; Gan, L.; Denecke, B.; et al. (2009). Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science Signaling, 2, ra81.
48. Hunter, M. P.; Ismail, N.; Zhang, X.; Aguda, B. D.; Lee, E. J.; Yu, L.; et al. (2008). Detection of microRNA expression in human peripheral blood microvesicles. PLoS One, 3, e3694.
49. Zampetaki, A.; Kiechl, S.; Drozdov, I.; Willeit, P.; Mayr, U.; Prokopi, M.; et al. (2010). Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circulation Research, 107, 810-817.
50. Fichtlscherer, S.; De Rosa, S.; Fox, H.; Schwietz, T.; Fischer, A.; Liebetrau, C.; et al. (2010). Circulating microRNAs in patients with coronary artery disease. Circulation Research, 107, 677-684.
51. Yao, R.; Ma, Y.; Du, Y.; Liao, M.; Li, H.; Liang, W.; et al. (2011). The altered expression of inflammation-related microRNAs with microRNA-155 expression correlates with Th17 differentiation in patients with acute coronary syndrome. Cellular and molecular immunology, 8, 486-495.
52. Wang, H.; Lu, H. M.; Yang, W. H.; Luo, C.; Lu, S. H.; Zhou, Y.; et al. (2012). The influence of statin therapy on circulating microRNA-92a expression in patients with coronary heart disease. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 24, 215-218.
53. Nazari-Jahantigh, M.; Wei, Y.; Noels, H.; Akhtar, S.; Zhou, Z.; Koenen, R. R.; et al. (2012). MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. The Journal of Clinical Investigation, 122, 4190-4202.